Navigation Links
EntreMed ENMD-2076 Phase 2 Data to Be Presented at ASCO Annual Meeting
Date:5/19/2011

ROCKVILLE, Md., May 19, 2011 /PRNewswire/ -- EntreMed, Inc. (Nasdaq: ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer today announced the presentation of clinical data for its Phase 2 study with ENMD-2076 in platinum-resistant ovarian cancer patients.  The data will be presented at the American Society of Clinical Oncology (ASCO) Annual Meeting to be held June 3 - 7, 2011 in Chicago, Illinois.

(Logo: http://photos.prnewswire.com/prnh/20010620/ENMDLOGO)-

Gynecologic Cancer Track: Poster SessionFriday, June 3, 2011 – 2:00 p.m. - 6:00 p.m. (CDT) Abstract No.: 5021Title: A Phase 2 Study of ENMD-2076 in platinum-resistant ovarian cancer Poster Board: 10, Location: E450aDiscussion SessionFriday, June 3, 2011 – 5:00 p.m. - 6:00 p.m. (CDT)Location: E354bAbout ENMD-2076ENMD-2076 is an orally-active, Aurora A/angiogenic kinase inhibitor with a unique kinase selectivity profile and multiple mechanisms of action. Preclinical studies with ENMD-2076 demonstrated significant antitumor activity, including tumor regression, in multiple solid and hematological malignancies. ENMD-2076 has been shown to inhibit a distinct profile of angiogenic tyrosine kinase targets in addition to the Aurora A kinase. Aurora kinases are key regulators of mitosis (cell division), and are often over-expressed in human cancers. ENMD-2076 also targets the VEGFR, Flt-3 and FGFR3 kinases which have been shown to play important roles in the pathology of several cancers. While ENMD-2076 is currently in a Phase 2 trial in ovarian cancer, preclinical and clinical activities are ongoing in assessing the compound's applicability in other forms of cancer.

About EntreMedEntreMed, Inc. is a clinical-stage pharmaceutical company committed to developing ENMD-2076, a selective angiogenic kinase inhibitor, for the treatment of cancer.  
'/>"/>

SOURCE EntreMed, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. EntreMed Presents Data for Phase 2 Study of MKC-1 in Metastatic Breast Cancer
2. EntreMed Raises $20 Million to Support Clinical Development Program
3. EntreMed Reports Phase 1 PK and Preclinical Efficacy Results for ENMD-1198
4. EntreMed Shows Increased Survival With MKC-1 in Preclinical Renal Cell Cancer Model
5. EntreMed Commences Phase 2 Study with MKC-1 in Pancreatic Cancer
6. EntreMed to Present at The New York Society of Security Analysts Industry Conference
7. EntreMed Commences Phase 2 Study With MKC-1 in Ovarian/Endometrial Cancers
8. EntreMed Commences Continuous Dosing Clinical Trial For MKC-1
9. EntreMed Achieves a Key Milestone Through Initiation of ENMD-2076 Clinical Program
10. EntreMed to Highlight ENMD-2076 Kinase Inhibitor at 2008 AACR Annual Meeting
11. EntreMed Presents MKC-1 and ENMD-1198 Preclinical Data at AACR Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... 2015  Sutro Biopharma today announced that it ... vice president of alliance and project management. Dr. ... management of Sutro,s collaborative partnerships and the development ... bispecific antibodies and antibody-based therapeutics targeting immuno-oncology pathways. ... years of experience in the biopharmaceutical sector with ...
(Date:8/4/2015)... 4, 2015 Concord Medical Services Holdings Limited ("Concord ... management solution provider and operator of the largest network of ... , today announced it will release its financial results for ... August 17, 2015. Management will hold a conference ... a.m. EDT on August 18, 2015 (8:00 p.m. in ...
(Date:8/4/2015)... Aug. 4, 2015 Research and Markets ( ... "Alcohol Ethoxylate Market by Application (Household & Personal Care, ... Trends, Forecasts to 2019" report to their offering. ... was valued at $5,124.9 million in 2014 and is ... from 2014 to 2019. The data mentioned in the ...
Breaking Medicine Technology:Sutro Biopharma Appoints Nicki Vasquez, Ph.D. as VP of Alliance and Project Management 2Concord Medical to Report Second Quarter 2015 Financial Results on August 17, 2015 2Global Alcohol Ethoxylate Market 2015 - Market Trends, Forecasts to 2019 for the $5.1 Billion Industry 2Global Alcohol Ethoxylate Market 2015 - Market Trends, Forecasts to 2019 for the $5.1 Billion Industry 3
(Date:8/4/2015)... Scottsdale, Arizona (PRWEB) , ... August 04, 2015 , ... ... the New Foundation AZ, which is a 501(c) nonprofit organization. , According to the ... for the tournament. Sponsors will get a package that includes a complimentary foursome for ...
(Date:8/4/2015)... ... August 04, 2015 , ... Atlantic Health System, one ... to Work® and Fortune among the top five in their list of the 20 ... Morristown, Overlook, Newton and Chilton Medical Centers, Goryeb Children’s Hospital and Atlantic Rehabilitation, is ...
(Date:8/4/2015)... ... August 04, 2015 , ... Healthy Origins® Cognizin® Citicoline is ... trademark for Citicoline, a nutrient that supports memory function and healthly cognition.* , ... more of a semi-solid composition. Vegetarian capsules are also natural, non-toxic and ...
(Date:8/4/2015)... ... August 04, 2015 , ... Angelina Jolie is in it ... of women every year. Dr. Angela DeRosa, DO, MBA, CPE aka “Dr. ... takes the scary unknown out of menopause. , Myth #1: Menopause only affects ...
(Date:8/4/2015)... ... August 04, 2015 , ... School is almost back ... the sun and preparing for the back-to-school scramble. Dublin, OH family dentist , ... best time for the annual dental checkup. In fact, the dentist recently updated the ...
Breaking Medicine News(10 mins):Health News:The New Foundation AZ to Host Charity Golf Tournament 2Health News:The New Foundation AZ to Host Charity Golf Tournament 3Health News:Atlantic Health System Named a 'Best Workplace in Health Care' by Fortune, Great Place to Work® 2Health News:Atlantic Health System Named a 'Best Workplace in Health Care' by Fortune, Great Place to Work® 3Health News:Atlantic Health System Named a 'Best Workplace in Health Care' by Fortune, Great Place to Work® 4Health News:Healthy Origins® Introduces Cognizin® Citicoline in a Vegetarian Capsule 2Health News:Healthy Origins® Introduces Cognizin® Citicoline in a Vegetarian Capsule 3Health News:"Dr. Hot Flash" Debunks the Top 5 Menopause Myths 2Health News:"Dr. Hot Flash" Debunks the Top 5 Menopause Myths 3Health News:Dublin OH Family Dentist Offers Complimentary Back-to-School Cleanings, a Revamped Suite, and In-House Esthetician to Accommodate All Patients 2Health News:Dublin OH Family Dentist Offers Complimentary Back-to-School Cleanings, a Revamped Suite, and In-House Esthetician to Accommodate All Patients 3Health News:Dublin OH Family Dentist Offers Complimentary Back-to-School Cleanings, a Revamped Suite, and In-House Esthetician to Accommodate All Patients 4
... about validity, usefulness of some on the market , WEDNESDAY, ... of the White House Office of Management and Budget, is ... he took a genetic test to see if his body ... the results, his body is perfectly suited to the task, ...
... Thursday, October 15, 2009 marks the 35th anniversary of ... of 288 Ronald McDonald Houses in 52 countries and regions ... Region. These include the Philadelphia House,s two locations (on Chestnut ... Avenue); the Ronald McDonald House of Southern New Jersey, the ...
... EMERYVILLE, Calif., Oct. 14 Bionovo, Inc. (Nasdaq: BNVI ... of Medicine and Co-Director of the Women,s Cancer Program at ... Dr. Tripathy is a world renowned leader and researcher in ... to have one of the world,s foremost authorities in the ...
... ... employment to persevere in this difficult job market. Profiles International suggests that employees who ... ... 14, 2009 -- Profiles International, a developer of employee assessments and talent ...
... ... of innovative quit smoking program , ... Auckland, New Zealand (Vocus) October 14, 2009 -- The Quit Group, ... one year of successful operation with HSAGlobal,s STOMP text message-based smoking cessation service. Branded ...
... ... no hospital in Mississippi has more Five-Star Ratings than Baptist Medical ... healthcare ratings organization. Baptist is among the top 10 percent in ... to a comprehensive annual study released today by HealthGrades. Baptist achieved ...
Cached Medicine News:Health News:Are Commercial Genetic Tests Worth Taking? 2Health News:Are Commercial Genetic Tests Worth Taking? 3Health News:Philadelphia-Born Ronald McDonald House(R) Program Celebrates 35 Years 2Health News:Philadelphia-Born Ronald McDonald House(R) Program Celebrates 35 Years 3Health News:Bionovo Adds Dr. Debu Tripathy to Their Medical Advisory Board 2Health News:Bionovo Adds Dr. Debu Tripathy to Their Medical Advisory Board 3Health News:As Unemployment Continues to Rise, Profiles International Encourages Employers and Employees to Focus on Value 2Health News:As Unemployment Continues to Rise, Profiles International Encourages Employers and Employees to Focus on Value 3Health News:First Commercial Text Messaging Smoking Cessation Service Marks One Year of Operation 2Health News:First Commercial Text Messaging Smoking Cessation Service Marks One Year of Operation 3Health News:Baptist Medical Center's Patient Outcomes Among Highest in the Nation, According to Independent Study 2Health News:Baptist Medical Center's Patient Outcomes Among Highest in the Nation, According to Independent Study 3Health News:Baptist Medical Center's Patient Outcomes Among Highest in the Nation, According to Independent Study 4
... agitators offer a wide range of storage ... drawer storage platform to agitate smoothly, eliminating ... down and squeak. Sturdy, one-piece perforated drawers ... circulation for your platelets., ,i.Series platelet agitators ...
Platelet agitator....
The "s" series shakers are available in orbital, reciprocating and Blood Bank Platelet versions....
The "s" series shakers are available in orbital, reciprocating and Blood Bank Platelet versions....
Medicine Products: